Preformulation studies of l-glutathione: physicochemical properties, degradation kinetics, and in vitro cytotoxicity investigations

Abstract

Objectives: l-Glutathione (GSH) is an endogenous tripeptide with super antioxidant properties. In this study, preformulation parameters of GSH and its degradation products were fully investigated.

Significance: To date, no experimental preformulation data is available for GSH. Therefore, to the author’s knowledge, this is the first study to experimentally determine the preformulation parameters of GSH, which can be considered more reliable for further studies.

Methods: An HPLC method for GSH was optimized and validated to accurately quantify the GSH amount in solution, used to investigate GSH’s solubility and Log P. Differential Scanning Calorimeter and Thermogravimetric Analyzer were used to evaluate the thermal properties of GSH. Polarized microscope and Fourier-transform Infrared Spectroscopy were used to determine GSH’s crystal habits and functional groups, respectively. Forced degradation kinetics and the degradation products were investigated and identified by LC-MS, respectively. GSH’s cellular cytotoxicity on fibroblasts was investigated by MTT assay.

Results: It was determined that GSH has high aqueous solubility (252.7 mg/mL), low Log P (−3.1), a melting endotherm of 195 °C and decomposition at 210°C, negligible moisture content, and a rectangular/cylindrical-shaped crystalline form. Seven degradation products were identified; one of the major degradation products of GSH under different conditions is first order kinetic oxidation into glutathione disulfide. No cytotoxicity was observed when fibroblasts were treated with GSH (0.005–10.000 mg/mL).

Conclusions: Precise preformulation parameters of GSH were obtained, and these are imperative for the development and optimization of advanced GSH formulations.

Keywords:

• GSH
• preformulation
• LC-MS
• physicochemical properties
• forced degradation kinetics
• distribution and partition coefficient
• cytotoxicity
• MTT assay

Disclosure statement

The authors have no conflicts of interest to disclose.